Gene · 10221
Papers1,541
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,541
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease. | Eur Cardiol | 2023 | 37860700 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| N6-methyladenosine modification-a key player in viral infection. | Cell Mol Biol Lett | 2023 | 37828480 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| Targeting cis-regulatory elements of FOXO family is a novel therapeutic strategy for induction of leukemia cell differentiation. | Cell Death Dis | 2023 | 37773170 | PubTator, text mining | PubMed |
| Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges. | Pharmaceuticals (Basel) | 2023 | 37765015 | PubTator, text mining | PubMed |
| Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. | Biomolecules | 2023 | 37759756 | PubTator, text mining | PubMed |
| Advances in genetic variation in metabolism-related fatty liver disease. | Front Genet | 2023 | 37753315 | PubTator, text mining | PubMed |
| Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease. | J Korean Med Sci | 2023 | 37750369 | PubTator, text mining | PubMed |
| Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV. | Front Immunol | 2023 | 37711619 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
| Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. | Nat Genet | 2023 | 37709864 | PubTator, text mining | PubMed |
| Comprehensive analyses of fatty acid metabolism-related lncRNA for ovarian cancer patients. | Sci Rep | 2023 | 37673886 | PubTator, text mining | PubMed |
| Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability. | iScience | 2023 | 37664595 | PubTator, text mining | PubMed |
| Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders. | medRxiv | 2023 | 37645746 | PubTator, text mining | PubMed |
| Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 37621646 | PubTator, text mining | PubMed |
| Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell models. | Nat Mach Intell | 2023 | 37615030 | PubTator, text mining | PubMed |
| Changes in brain structure in subjects with resistance to thyroid hormone due to THRB mutations. | Thyroid Res | 2023 | 37592301 | PubTator, text mining | PubMed |
| AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology. | Blood Adv | 2023 | 37582288 | PubTator, text mining | PubMed |
| Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies. | J Clin Transl Hepatol | 2023 | 37577225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10221/papers?page=6